Redhill Biopharma
RDHL
#11160
Rank
C$3.58 M
Marketcap
C$0.40
Share price
-13.08%
Change (1 day)
-73.29%
Change (1 year)

Redhill Biopharma (RDHL) - Total debt

Total debt on the balance sheet as of June 2026 : C$1.54 Million

According to Redhill Biopharma's latest financial reports the company's total debt is C$1.54 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Redhill Biopharma - Total debt on balance sheet (from 2018 to 2026)

Total debt by year

Year Total debt Change
2025-12-31C$1.46 M186.84%
2024-12-31C$0.51 M-67.16%
2023-12-31C$1.55 M-99.07%
2022-12-31C$0.16 B48.77%
2021-12-31C$0.11 B1%
2020-12-31C$0.11 B2123.88%
2019-12-31C$4.98 M
2018-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Sanofi
SNY
C$38.58 B 2,502,969.77%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$77.30 B 5,014,411.63%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$45.08 B 2,924,355.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$24.19 B 1,569,574.42%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
C$2.79 M 81.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel